|
Published by: Euromonitor International
Published: Jul. 3, 2012 - 54 Pages
Table of Contents- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ITALY
- Euromonitor International
- July 2012
- LIST OF CONTENTS AND TABLES
- Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Category Data
- Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
- Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
- Table 3 Sales of Decongestants by Category: Value 2006-2011
- Table 4 Sales of Decongestants by Category: % Value Growth 2006-2011
- Table 5 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
- Table 6 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
- Table 7 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
- Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
- Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
- Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016
- Aziende Chimiche Riunite Angelini Francesco Acraf SpA in Consumer Health (italy)
- Strategic Direction
- Key Facts
- Summary 1 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts
- Summary 2 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators
- Company Background
- Production
- Summary 3 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics
- Competitive Positioning
- Summary 4 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2011
- Bayer SpA in Consumer Health (italy)
- Strategic Direction
- Key Facts
- Summary 5 Bayer SpA: Key Facts
- Summary 6 Bayer SpA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Summary 7 Bayer SpA: Competitive Position 2011
- Bracco SpA in Consumer Health (italy)
- Strategic Direction
- Key Facts
- Summary 8 Bracco SpA: Key Facts
- Summary 9 Bracco SpA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Summary 10 Bracco SpA: Competitive Position 2011
- Chiesi Farmaceutici SpA in Consumer Health (italy)
- Strategic Direction
- Key Facts
- Summary 11 Chiesi Farmaceutici SpA: Key Facts
- Summary 12 Chiesi Farmaceutici SpA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Summary 13 Chiesi Farmaceutici SpA: Competitive Position 2011
- Perfetti Van Melle SpA in Consumer Health (italy)
- Strategic Direction
- Key Facts
- Summary 14 Perfetti Van Melle SpA: Key Facts
- Summary 15 Perfetti Van Melle SpA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Summary 16 Perfetti Van Melle SpA: Competitive Position 2011
- Recordati Industria Chimica E Farmaceutica SpA in Consumer Health (italy)
- Strategic Direction
- Key Facts
- Summary 17 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
- Summary 18 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
- Company Background
- Production
- Summary 19 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics
- Competitive Positioning
- Summary 20 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2011
- Sanofi-aventis SpA in Consumer Health (italy)
- Strategic Direction
- Key Facts
- Summary 21 Sanofi-Aventis SpA: Key Facts
- Summary 22 Sanofi-Aventis SpA: Operational Indicators
- Company Background
- Production
- Competitive Positioning
- Summary 23 Sanofi-Aventis SpA: Competitive Position 2011
- Zambon Italia SpA in Consumer Health (italy)
- Strategic Direction
- Key Facts
- Summary 24 Zambon Italia SpA: Key Facts
- Summary 25 Zambon Italia SpA: Operational Indicators
- Company Background
- Production
- Summary 26 Zambon Italia SpA: Production Statistics
- Competitive Positioning
- Summary 27 Zambon Italia SpA: Competitive Position 2011
- Executive Summary
- Task-specific and New Products Led Growth
- Consumer Health Is Increasingly Fragmented
- Health and Beauty Retailers Keep the Lion's Share
- Consumer Health Will Post Further Growth Over Forecast Period
- Key Trends and Developments
- Increasing Awareness of Prevention - Health and Beauty
- Poor Economy Has A Varied Impact on OTC Products and Dietary Supplements
- Consumers Still Lack Trust in Generics, But Private Label Develops Slowly
- Chemists/pharmacies Is Still the Cornerstone of Distribution
- Increasing Interest in Herbal/traditional Products and Organic Ingredients
- Market Indicators
- Table 11 Consumer Expenditure on Health Goods and Medical Services 2006-2011
- Table 12 Life Expectancy at Birth 2006-2011
- Market Data
- Table 13 Sales of Consumer Health by Category: Value 2006-2011
- Table 14 Sales of Consumer Health by Category: % Value Growth 2006-2011
- Table 15 Consumer Health Company Shares 2007-2011
- Table 16 Consumer Health Brand Shares 2008-2011
- Table 17 Penetration of Private Label by Category 2006-2011
- Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
- Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
- Table 20 Forecast Sales of Consumer Health by Category: Value 2011-2016
- Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
- Appendix
- Non-prescription Medicines: Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication/self-care and Preventative Medicine Impacting Consumer Health
- Switches
- Summary 28 OTC - Switches 2010-2011
- Definitions
- Sources
- Summary 29 Research Sources
AbstractThe influenza season in 2011 was worse than in 2010 and the preceding years, seeing the rate at least as double. Nevertheless, consumers continued to express concern regarding the adverse side-effects of allopathic products. As a result, Italians increasingly shifted towards natural remedies. In cases of coughs, colds, flu and pharyngeal irritations, Italian consumers are accustomed to deciding themselves what product to use, usually well-known syrups and/or tablets, often after taking advice...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?- Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Get full details about this report >>
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports,
company profiles and country profiles from over 720 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
|